VTU Technology and Boehringer Ingelheim strengthen their global microbial technology collaboration

VALIDOGEN GmbH News Releases

Find the latest News from VALIDOGEN GmbH

Home / News Releases

VTU Technology and Boehringer Ingelheim strengthen their global microbial technology collaboration

Wednesday 27th April 2016

By VALIDOGEN GmbH Learn More >

VTU bringing advanced protein expression to key European conferences

Tuesday 15th March 2016

By VALIDOGEN GmbH Learn More >

VTU bringing latest technologies to Pichia 2016, Turkey and 4th BioproScale Symposium, Germany

Friday 11th March 2016

By VALIDOGEN GmbH Learn More >

VTU bringing advanced protein expression to BIO-Europe

Tuesday 27th October 2015

By VALIDOGEN GmbH Learn More >

VTU Technology showcasing breakthrough technologies at BIO-International

Tuesday 26th May 2015

By VALIDOGEN GmbH Learn More >

VTU Technology and Biomay have signed license agreement

Wednesday 20th May 2015

By VALIDOGEN GmbH Learn More >

Boehringer Ingelheim renews global technology collaboration agreement with VTU Technology

Tuesday 10th February 2015

By VALIDOGEN GmbH Learn More >

VTU Technology to offer unique combination of technologies for the high-level production of proteins with human-like glycosylation using…

Wednesday 3rd December 2014

By VALIDOGEN GmbH Learn More >

VTU brings broadest and most versatile protein expression platform to BIO International Convention 2014

Thursday 8th May 2014

By VALIDOGEN GmbH Learn More >

VTU to Present Groundbreaking Expression Technologies at Pichia 2014

Thursday 13th February 2014

By VALIDOGEN GmbH Learn More >

VTU Technology to Showcase Next Generation Protein Expression Platform

Tuesday 1st October 2013

By VALIDOGEN GmbH Learn More >

Therapeutic, Recombinant Human Serum Albumin (rHSA) VTU Technology Signs Agreement with Minapharm Pharmaceuticals

Tuesday 27th November 2012

By VALIDOGEN GmbH Learn More >